However, the fine analysis of tumor-infiltrating immune populations let us demonstrate a decrease in the frequency of Treg and M-MDSC-LC in mice treated with T. usneoides compared with the PBS group (Figure 4F), but no differences in the frequency of DCs (Figure 4F,G) and the activated CD8+ T cells (Figure 4H). The gene discussed is CD8A; the disease is neoplasm.